What problem does this paper attempt to address?

The problem this paper attempts to address is the role of leucine-rich repeat kinase 2 (LRRK2) in thioacetamide (TAA)-induced acute liver failure (ALF) and hepatic encephalopathy (HE) in mice. Specifically, the study aims to explore whether the lack of LRRK2 affects the development of TAA-induced ALF and HE and to further elucidate its potential mechanisms. ### Research Background - **Hepatic Encephalopathy (HE)**: HE is a neuropsychiatric disorder associated with acute or chronic liver disease, characterized by progressive motor dysfunction and cognitive impairment. - **Inflammatory Response**: In recent years, inflammation-mediated neurotoxicity has received increasing attention in the pathogenesis of HE, although the ammonia toxicity hypothesis has been widely recognized. - **Role of LRRK2**: LRRK2 is a complex GTPase/kinase involved in regulating various cellular processes, including the autophagy-lysosome pathway. Mutations in LRRK2 are closely related to Parkinson's disease (PD). However, the role of LRRK2 in liver inflammation and HE remains unclear. ### Research Objectives - **Explore the role of LRRK2 in TAA-induced HE**: By establishing mouse models of LRRK2 wild-type (WT), LRRK2 G2019S mutant (Lrrk2G2019S), and LRRK2 knockout (Lrrk2−/−), evaluate the impact of LRRK2 deficiency on TAA-induced ALF and HE. - **Analyze the impact of LRRK2 deficiency on liver and brain pathological changes**: Through behavioral tests, biochemical indicators detection, pathological examination, and electron microscopy observation, comprehensively assess the impact of LRRK2 deficiency on mouse survival rate, neurological function, liver injury, and inflammatory response. ### Main Findings - **LRRK2 deficiency significantly increases the mortality rate of TAA-HE mice**: The survival rate of the Lrrk2−/−-HE group was significantly lower than that of the WT-HE and Lrrk2G2019S-HE groups. - **LRRK2 deficiency exacerbates neurological dysfunction in TAA-HE mice**: Mice in the Lrrk2−/−-HE group exhibited more severe motor coordination disorders, fatigue, and muscle tone disorders in behavioral tests. - **LRRK2 deficiency aggravates liver injury and inflammatory response**: Mice in the Lrrk2−/−-HE group showed more pronounced liver congestion, swelling, dark red color, rough surface, and extensive necrosis. - **LRRK2 deficiency affects the autophagy-lysosome pathway**: The liver autophagy level decreased, and the phosphorylation of lysosomal Rab10 was abnormal in the Lrrk2−/−-HE group. ### Conclusion LRRK2 deficiency may exacerbate TAA-induced ALF and HE, manifested by enhanced inflammatory responses in the liver and brain. These findings suggest that caution should be exercised regarding the adverse effects on the liver when clinically applying LRRK2 inhibitors.

Deficiency of leucine-rich repeat kinase 2 aggravates thioacetamide-induced acute liver failure and hepatic encephalopathy in mice

The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

Absence of TNFR1 promotes a protective response in the early phase of hepatic encephalopathy induced by thioacetamide in mice

Therapeutic Effect of Levetiracetam Against Thioacetamide-Induced Hepatic Encephalopathy Through Inhibition of Oxidative Stress and Downregulation of NF-κB, NLRP3, iNOS/NO, Pro-Inflammatory Cytokines and Apoptosis

Protective effect of<i>Lactobacillus salivarius</i>Li01 on thioacetamide-induced acute liver injury and hyperammonaemia

Protective Effect of Lactobacillus Salivarius Li01 on Thioacetamide‐induced Acute Liver Injury and Hyperammonaemia

Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice

SIRT3 inhibitor 3-TYP exacerbates thioacetamide-induced hepatic injury in mice

Inhibition of RKIP aggravates thioacetamide-induced acute liver failure in mice

Role of leucine-rich repeat kinase 2 in severe acute pancreatitis

Integrated transcriptomic analysis of liver and kidney after 28 days of thioacetamide treatment in rats

LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity

The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases

Mechanism of Alzheimer type II astrocyte development in hepatic encephalopathy

Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation

Inhibition of autotaxin alleviates pathological features of hepatic encephalopathy at the level of gut–liver–brain axis: an experimental and bioinformatic study

Myeloid-derived TLR4-TRIF signaling pathway mediates oxidative stress in LPS/D-GalN-induced acute liver failure

Intestinal Dysbacteriosis Contributes to Persistent Cognitive Impairment after Resolution of Acute Liver Failure

Hepatic Overexpression of Annexin A1 and A2 in Thioacetamide-Primed Mice Protects Them Against Acetaminophen-Induced Liver Failure and Death

Aldehyde Dehydrogenase 2 Ameliorates LPS-Induced Acute Kidney Injury Through Detoxification of 4-HNE and Suppression of the MAPK Pathway